NXGL

Nexgel Inc

3.96

Oct 26 • 3:59 PM ET -1.07 (-21.27%)

3.58

Aftermarket • 4:52 PM ET -0.38 (-9.60%)

Healthcare Medical Instruments & Supplies USA Nano NASD

Today, 3:02 PMNo clear catalyst identified for Nexgel 21% regular-hours drop

Peers: CUPR SMTI RGNT RVP NEPH FEMY MLSS DXR HBIO POCI

| Held by: VXF DFAS DFMC

Scroll to Statements

Index	-
Market Cap	1.94M
Enterprise Value	8.21M
Income	-6.18M
Sales	12.07M
Book/sh	10.20
Cash/sh	3.49
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	19
IPO	Dec 22, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	0.16
P/B	0.39
P/C	1.13
P/FCF	-
EV/EBITDA	-
EV/Sales	0.68
Quick Ratio	0.27
Current Ratio	0.43
Debt/Eq	1.51
LT Debt/Eq	1.32
Option/Short	No / Yes

EPS (ttm)	-14.35
EPS next Y	-4.40
EPS next Q	-4.80
EPS this Y	-147.37%
EPS next Y	76.60%
EPS next 5Y	49.14%
EPS past 3/5Y	23.45% -77.45%
Sales past 3/5Y	77.33% 76.12%
EPS Y/Y TTM	-78.48%
Sales Y/Y TTM	3.38%
EPS Q/Q	-364.19%
Sales Q/Q	27.81%
Earnings	Aug 14 BMO
EPS/Sales Surpr.	-233.33% -14.58%

Insider Own	14.08%
Insider Trans	-33.66%
Inst Own	6.03%
Inst Trans	-
ROA	-34.21%
ROE	-128.59%
ROIC	-53.83%
Gross Margin	34.73%
Oper. Margin	-44.77%
Profit Margin	-51.26%
SMA20	-7.57%
SMA50	-27.28%
SMA200	-69.82%
Trades

Shs Outstand	0.49M
Shs Float	0.42M
Short Float	3.84%
Short Ratio	0.15
Short Interest	0.02M
52W High	54.26 -92.70%
52W Low	3.00 32.00%
Volatility	14.88% 21.62%
ATR (14)	0.85
RSI (14)	41.65
Beta	0.76
Rel Volume	0.45
Avg Volume	107.05K
Volume	48,477

Perf Week	-31.72%
Perf Month	13.79%
Perf Quarter	-55.04%
Perf Half Y	-67.38%
Perf YTD	-87.70%
Perf Year	-92.36%
Perf 3Y	-87.06%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	40.00
Prev Close	5.03
Price	3.96
Change %	-21.27%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-24-26	Downgrade	Maxim Group	Buy → Hold

Oct-12-26 08:30AM	NEXGEL Announces 1-for-20 Reverse Stock Split Effectiveness (GlobeNewswire)
Sep-23-26 09:29AM	NEXGEL Announces Dial-In Details for Investor Update Call (GlobeNewswire)
Sep-16-26 09:29AM	NEXGEL Announces Date for Investor Update Call (GlobeNewswire) -11.70%
Aug-20-26 04:05PM	NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE (GlobeNewswire) -14.79%
Aug-17-26 10:54AM	NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp (InvestorsHub) -33.54%
08:00AM	Loading…
08:00AM	NEXGEL Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Jun-04-26 09:00AM	NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th -18th (GlobeNewswire)
May-19-26 09:00AM	NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration (GlobeNewswire) +20.14%
May-13-26 08:30AM	NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical (GlobeNewswire) -8.10%
May-12-26 10:27AM	NEXGEL To Report First Quarter 2026 Financial Results on May 15th (GlobeNewswire)
May-06-26 09:00AM	NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience, to Board of Directors (GlobeNewswire)
Apr-27-26 09:00AM	NEXGEL Appoints Ian Blackman as Chief Financial Officer (GlobeNewswire) -6.04%
Apr-21-26 09:00AM	NEXGEL New Strategic Partner, Sequence LifeScience, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment (GlobeNewswire) +15.89%
Apr-17-26 03:37PM	NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET (GlobeNewswire)
Apr-15-26 04:12PM	NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction (GlobeNewswire) +27.12% -15.26%
09:00PM	Loading…
Apr-08-26 09:00PM	NexGel Inc (NXGL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com)
04:05PM	NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction (GlobeNewswire)
Mar-31-26 04:12PM	NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity (GlobeNewswire)
Mar-25-26 09:00AM	NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st (GlobeNewswire)
Mar-12-26 08:45AM	NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products (GlobeNewswire) +16.21%
Mar-10-26 08:45AM	NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products (GlobeNewswire) -15.77%
08:30AM	EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue (Benzinga)
Feb-10-26 09:00AM	NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence (GlobeNewswire)
Dec-16-25 08:00AM	NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor (GlobeNewswire)
Dec-11-25 08:00AM	NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx (GlobeNewswire) +22.67%
Nov-12-25 12:00AM	NexGel Inc (NXGL) Q3 2025 Earnings Call Highlights: Progress Towards Profitability Amidst ... (GuruFocus.com) -11.40%
Nov-11-25 04:10PM	NEXGEL Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-03-25 08:00AM	NEXGEL to Report Third Quarter 2025 Financial Results on November 11th (GlobeNewswire)
Oct-09-25 08:00AM	NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21 (GlobeNewswire)
Aug-13-25 03:14AM	NexGel Inc (NXGL) Q2 2025 Earnings Call Highlights: Revenue Doubles Amid Strategic Growth and ... (GuruFocus.com) -11.44%
04:05PM	Loading…
Aug-12-25 04:05PM	NEXGEL Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-06-25 08:00AM	NEXGEL to Report Second Quarter 2025 Financial Results on August 12th (GlobeNewswire) -6.96%
Aug-05-25 08:00AM	NEXGEL Appoints Chief Accounting Officer of Shutterstock, Steve Ciardiello, CPA, to its Board of Directors (GlobeNewswire)
Aug-01-25 08:00AM	NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) +14.23%
Jul-14-25 09:00AM	NEXGEL and STADA AG Announce Expansion of Partnership for North America (GlobeNewswire) -5.20%
May-21-25 09:00AM	NEXGEL to Participate in the 6th Annual CEO Networking Event Hosted by Semco Capital on June 2nd (GlobeNewswire) -5.13%
May-13-25 04:05PM	NEXGEL Reports First Quarter 2025 Financial Results (GlobeNewswire) -9.15%
May-09-25 09:00AM	NEXGEL to Report First Quarter 2025 Financial Results on May 13th (GlobeNewswire)
Apr-07-25 09:00AM	NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th (GlobeNewswire)
Mar-24-25 05:41PM	NEXGEL, Inc. (NXGL) Q4 2024 Earnings Call Transcript (SeekingAlpha) +14.44%
04:05PM	NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-21-25 09:00AM	iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025 (ACCESSWIRE)
Mar-19-25 09:00AM	NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th (GlobeNewswire)
Mar-13-25 09:00AM	NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025 (GlobeNewswire) -7.95%
Feb-13-25 09:00AM	NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025 (GlobeNewswire) +5.64%
Jan-22-25 09:00AM	NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025 (GlobeNewswire)
Jan-02-25 09:00AM	NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer (GlobeNewswire) -14.14%
Dec-06-24 08:30AM	iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024 (ACCESS Newswire)
Nov-21-24 09:00AM	NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024 (GlobeNewswire)
Nov-13-24 04:40PM	NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially (GlobeNewswire)
Nov-11-24 05:35PM	NEXGEL Announces $2,000,000 Registered Direct Offering (GlobeNewswire) +8.02% -10.00%
09:00AM	NEXGEL to Report Third Quarter 2024 Financial Results on November 13th (GlobeNewswire)
Oct-11-24 09:05AM	NexGel expects Q3 revenue approx $2.85M (TipRanks)
09:00AM	NEXGEL to Participate in Upcoming October Investor Conferences (GlobeNewswire)
Oct-10-24 09:00AM	NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially (GlobeNewswire) +18.75%
Oct-04-24 09:00AM	NEXGEL Appoints Kip Crecca to its Scientific Advisory Board (GlobeNewswire)
Sep-18-24 09:00AM	NEXGEL's Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash Collection (GlobeNewswire)
Aug-14-24 04:25PM	NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million (GlobeNewswire) -5.61%
Aug-12-24 09:15AM	NEXGEL to Report Second Quarter 2024 Financial Results on August 14th (GlobeNewswire)
09:00AM	NEXGEL Announces $1,110,000 Registered Direct Offering Led by Insiders (GlobeNewswire)
Jul-18-24 09:15AM	NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal (GlobeNewswire)
Jul-08-24 04:05PM	NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively (GlobeNewswire) -7.69% +9.31%
Jun-27-24 09:00AM	NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation (GlobeNewswire)
Jun-11-24 08:40AM	NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America (GlobeNewswire)
May-16-24 09:00AM	NEXGEL Acquires International Beauty Brand, Silly George (GlobeNewswire)
May-13-24 08:53PM	NXGL Stock Earnings: NexGel Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year (GlobeNewswire)
May-09-24 08:00AM	NEXGEL to Report First Quarter 2024 Financial Results on May 13th (GlobeNewswire)
May-06-24 04:05PM	NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024 (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-18-24 08:00AM	NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024 (GlobeNewswire)
Apr-02-24 10:28AM	NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript (Insider Monkey) +6.25%
Apr-01-24 12:52PM	NXGL Stock Earnings: NexGel Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -17.95%
07:50AM	NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year (GlobeNewswire)
Mar-27-24 09:00AM	NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday (GlobeNewswire)
Mar-21-24 09:00AM	NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th (GlobeNewswire)
Mar-11-24 11:00AM	RETRANSMISSION: iAccess Alpha's Buyside Best Ideas Spring Virtual Conference March 12th and 13th, 2024 (ACCESSWIRE)
Mar-04-24 08:30AM	NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th (GlobeNewswire) +15.53%
Feb-21-24 04:05PM	NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders (GlobeNewswire) +16.83%
Jan-18-24 09:00AM	NEXGEL to Present at The Microcap Conference, January 30th through February 1st (GlobeNewswire)
Jan-09-24 08:30AM	NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024 (GlobeNewswire)
Dec-11-23 08:00AM	NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America (GlobeNewswire) +7.87%
Dec-05-23 08:00AM	NEXGEL Acquires Kenkoderm Psoriasis Skincare Line (GlobeNewswire)
Nov-20-23 10:00AM	NEXGEL, Inc. (NASDAQ:NXGL) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-16-23 06:35AM	3 Stocks Youll Regret Not Buying Soon: November 2023 (InvestorPlace)
Nov-13-23 04:05PM	NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year (GlobeNewswire)
Nov-02-23 09:00AM	NEXGEL to Report Third Quarter 2023 Financial Results on November 13th (GlobeNewswire)
Oct-30-23 08:00AM	NEXGEL Secures Supply Agreement with AbbVie (GlobeNewswire)
Sep-26-23 09:49AM	NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd (GlobeNewswire)
Sep-15-23 11:02AM	Director Scott Henry Acquires 10,500 Shares of NexGel Inc (GuruFocus.com) -8.89%
Aug-14-23 04:05PM	NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year (GlobeNewswire) -5.91%
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
Aug-10-23 06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research) -11.22%
Aug-09-23 06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research) -12.13%
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research) +8.14%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Levy Adam R.	Affilaite	Sep 29 '26	Proposed Sale	0.16	21,500	3,489		Sep 30 01:33 PM
Levy Adam R.	Chief Executive Officer	Jun 18 '26	Sale	0.59	6,000	3,553	327,692	Jun 23 07:51 PM
Levy Adam R.	Chief Executive Officer	Jun 23 '26	Sale	0.59	5,000	2,967	322,692	Jun 23 07:51 PM
Levy Adam R.	Chief Executive Officer	Jun 11 '26	Sale	0.61	3,000	1,841	333,692	Jun 15 05:39 PM
Levy Adam R.	Chief Executive Officer	Jun 04 '26	Sale	0.59	3,000	1,781	339,692	Jun 09 07:17 PM
Levy Adam R.	Chief Executive Officer	Jun 08 '26	Sale	0.55	3,000	1,641	336,692	Jun 09 07:17 PM
Levy Adam R.	Chief Executive Officer	Jun 01 '26	Sale	0.59	2,000	1,172	342,692	Jun 03 06:53 PM
Levy Adam R.	Chief Executive Officer	May 28 '26	Sale	0.61	7,000	4,241	347,692	May 29 08:03 PM
Levy Adam R.	Chief Executive Officer	May 29 '26	Sale	0.60	3,000	1,801	344,692	May 29 08:03 PM
Levy Adam R.	Chief Executive Officer	May 27 '26	Sale	0.60	3,000	1,792	354,692	May 29 08:03 PM
Levy Adam R.	Officer	May 27 '26	Proposed Sale	0.54	50,000	27,065		May 27 10:43 AM
Levy Adam R.	Chief Executive Officer	Dec 22 '25	Sale	1.61	6,000	9,661	361,692	Dec 29 08:47 AM
Levy Adam R.	Chief Executive Officer	Dec 24 '25	Sale	1.57	4,000	6,286	357,692	Dec 29 08:47 AM
Levy Adam R.	Officer	Dec 22 '25	Proposed Sale	1.64	10,000	16,400		Dec 22 11:24 AM
Levy Adam R.	Chief Executive Officer	Nov 06 '25	Sale	2.52	4,000	10,084	367,692	Nov 07 08:00 PM

NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It operates through the NexGel and CGN segments. The NexGel segment consists of the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. The CGN segment consists of the CGN JV used for the company's converting and packaging business, which is based in Granbury, Texas. The company was founded on January 13, 2009, and is headquartered in Langhorne, PA.

Interim CEO & DirectorMr. Brian J. Kieser CPA

Chief Financial OfficerMr. Ian Blackman CPA

Vice President of OperationsMr. Gregory J. Robb

Managing Director of KCSA Strategic CommunicationsMr. Valter Pinto

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NXGL

Nexgel Inc

Upgrade your Finviz experience